HEALTH AND BIOTECH STARTUPS RECEIVED MAJORITY SERIES A FUNDING

Summary from the TLDR Founders newsletter

Biotech and healthcare startups are dominating U.S. Series A funding in 2024, accounting for 53% of total commitments despite representing less than a third of deals. These sectors are attracting the largest Series A rounds, with six out of the top ten financings going to biotechs, including supergiant rounds for Xaira Therapeutics and Mirador Therapeutics. As biotech and healthcare capture a growing share of Series A investment, there are concerns about the availability of funding for startups in other sectors, particularly those that raised seed funding during the recent record-breaking period.